Melissa A.
Melissa A. Batis-Carver, Titusville, FL US
Patent application number | Description | Published |
---|---|---|
20150059347 | METHOD FOR CONTROLLING COUPLING BETWEEN A FIRST MACHINE AND A SECOND MACHINE - A method for controlling coupling between a first machine including a first rotating shaft having an associated first positional phase angle defined by a first shaft indicia and a second machine including a second rotating shaft having an associated second positional phase angle defined by a second shaft indicia. A rotational speed and rotational angle of the first shaft are monitored, and rotation of the second shaft is controlled by bringing the second shaft to a predetermined rotational speed relative to the first shaft speed. Acceleration of the second shaft is controlled such that the second shaft indicia is within a predetermined angle relative to the first shaft indicia upon the second shaft being brought to the predetermined rotational speed, at which point the first and second shafts are coupled such that the second shaft indicia is within the predetermined angle relative to the first shaft indicia. | 03-05-2015 |
Melissa A. Bollbach, Richmond, VA US
Patent application number | Description | Published |
---|---|---|
20100286840 | VOLTAGE CONSERVATION USING ADVANCED METERING INFRASTRUCTURE AND SUBSTATION CENTRALIZED VOLTAGE CONTROL - A voltage control and conservation (VCC) system is provided, which includes three subsystems, including an energy delivery (ED) system, an energy control (EC) system and an energy regulation (ER) system. The VCC system is configured to monitor energy usage at the ED system and determine one or more energy delivery parameters at the EC system. The EC system may then provide the one or more energy delivery parameters to the ER system to adjust the energy delivered to a plurality of users for maximum energy conservation. | 11-11-2010 |
20130030591 | VOLTAGE CONSERVATION USING ADVANCED METERING INFRASTRUCTURE AND SUBSTATION CENTRALIZED VOLTAGE CONTROL - A voltage control and conservation (VCC) system is provided, which includes three subsystems, including an energy delivery (ED) system, an energy control (EC) system and an energy regulation (ER) system. The VCC system is configured to monitor energy usage at the ED system and determine one or more energy delivery parameters at the EC system. The EC system may then provide the one or more energy delivery parameters to the ER system to adjust the energy delivered to a plurality of users for maximum energy conservation. | 01-31-2013 |
20140312693 | VOLTAGE CONSERVATION USING ADVANCED METERING INFRASTRUCTURE AND SUBSTATION CENTRALIZED VOLTAGE CONTROL - A voltage control and conservation (VCC) system is provided, which includes three subsystems, including an energy delivery (ED) system, an energy control (EC) system and an energy regulation (ER) system. The VCC system is configured to monitor energy usage at the ED system and determine one or more energy delivery parameters at the EC system. The EC system may then provide the one or more energy delivery parameters to the ER system to adjust the energy delivered to a plurality of users for maximum energy conservation. | 10-23-2014 |
Melissa A. (bollbach) Peskin, Richmond, VA US
Patent application number | Description | Published |
---|---|---|
20150088330 | VOLTAGE CONSERVATION USING ADVANCED METERING INFRASTRUCTURE AND SUBSTATION CENTRALIZED VOLTAGE CONTROL - A voltage control and conservation (VCC) system is provided, which includes three subsystems, including an energy delivery (ED) system, an energy control (EC) system and an energy regulation (ER) system. The VCC system is configured to monitor energy usage at the ED system and determine one or more energy delivery parameters at the EC system. The EC system may then provide the one or more energy delivery parameters to the ER system to adjust the energy delivered to a plurality of users for maximum energy conservation. | 03-26-2015 |
Melissa A. Byland, Bentonville, AR US
Patent application number | Description | Published |
---|---|---|
20150120419 | SYSTEM AND METHOD FOR PROVIDING SALE ITEMS - A system is provided that allows a customer to receive a guaranteed sales item when a sales item is not available on-hand at a retail store location. In one implementation, a limited in-store sale of an item may be provided such that if the customer meets certain criteria associated with the sale, that the customer is guaranteed the item, even if the item is not located at the retail location. In another implementation, each customer that is located at the retail store within a certain prescribed time of the sale may be guaranteed that the item is received by certain time. | 04-30-2015 |
Melissa A. Checky, Mahtomedi, MN US
Patent application number | Description | Published |
---|---|---|
20160030877 | End of Service Life Indicating Systems For Layered Filter Cartridges - Layered filtered cartridge systems with an End of Service Life Indicating system include a filter cartridge that includes filter media. The filter media includes a multi-layer construction, of a first sorbent layer, a second sorbent layer, and a sensing element adjacent to the first and second sorbent layers such that an indicating element of the sensing element is located at the interface between the first and second sorbent layers. The first sorbent layer has a higher adsorption capacity and/or higher adsorption rate than the second sorbent layer. The sensing element indicates the passage of an adsorption wavefront through the filter cartridge. | 02-04-2016 |
Melissa A. Frilot, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20130098690 | REPAIRED WEAR AND BUCKLE RESISTANT DRILL PIPE AND RELATED METHODS - The present invention embodies a drill pipe in which various damaged sections of the pipe are repaired in order to maintain or improve the wear and buckle resistance of the drill pipe. The sections are strengthened using various hardening methods such as heat treatment processes and/or expansion techniques. A sleeve can also be applied to the strengthened portions. Surface enhancers, such as hardbanding, can be applied to the strengthened portions or the sleeve in order to provide abrasion resistance or to reduce friction. | 04-25-2013 |
Melissa A. Grette-Compton, Eagan, MN US
Patent application number | Description | Published |
---|---|---|
20120087089 | CARDLOCK CLAMP - A cardlock clamp is described that is used to secure an electronics module in a channel of a card cage. The cardlock clamp is configured to convert an input compression force into clamping forces in at least two radial directions perpendicular to the input compression force. The described cardlock clamp also provides self-alignment and self-center functions for the electronics module inserted into the channel. Further, variations of the cardlock clamp are described that provide more effective heat transfer from the electronics module to the card cage. | 04-12-2012 |
20140016998 | CARDLOCK CLAMP - A cardlock clamp is described that is used to secure an electronics module in a channel of a card cage. The cardlock clamp is configured to convert an input compression force into clamping forces in at least two radial directions perpendicular to the input compression force. The described cardlock clamp also provides self-alignment and self-center functions for the electronics module inserted into the channel. Further, variations of the cardlock clamp are described that provide more effective heat transfer from the electronics module to the card cage. | 01-16-2014 |
Melissa A. Grunlan, College Station, TX US
Patent application number | Description | Published |
---|---|---|
20100056894 | Self-Cleaning Membrane for Implantable Biosensors - The present disclosure relates, according to some embodiments, to compositions, devices, systems, and methods including and/or for preparing and/or using a thermoresponsive nanocomposite hydrogel. In some embodiments, the disclosure relates to methods of preparing a hydrogel including, for example, photochemically curing an aqueous solution of NIPAAm and copoly(dimethylsiloxane/methylvinylsiloxane) colloidal nanoparticles (˜219 nm). At temperatures above a volume phase transition temperature (VPTT) of ˜33-34° C., a hydrogel may deswell and become hydrophobic, while lowering the temperature below a VPTT may cause the hydrogel to swell and become hydrophilic. | 03-04-2010 |
Melissa A. Kacena, Zionsville, IN US
Patent application number | Description | Published |
---|---|---|
20110288652 | MATERIALS AND METHODS FOR TREATING CRITICALLY SIZED DEFECTS IN MOUSE BONE - Scaffolds equipped to include biologically active reagents such as proteins sized and engineered specifically for use in a mouse were made and implanted into mice. The scaffold was specifically designed for use in a mouse femoral critical sized defect Scaffolds. Special care was taken when casting these scaffolds to ensure that the material used to form the body of the scaffold did not include defects such as a large number of macroscopic holes that could compromise the structural integrity of these very small devices. Some of these scaffolds include a hollow center that accommodate a rod that ran the longitudinal length of the scaffold extending into the adjacent bone to anchor the scaffold to the bone. Scaffold also include at least one channel that extended from the outside of the structure towards its center and could be hold a liquid or paste comprising for example exogenous BMP-2. | 11-24-2011 |
20120115222 | COMPOSITION AND METHOD FOR MAINTENANCE, DIFFERENTIATION, AND PROLIFERATION OF STEM CELLS - Compositions and methods for the proliferation, differentiation, and maintenance of stem cells are described. Preferred are the use of hematopoietic stem cells in combination with a collagen matrix. | 05-10-2012 |
20130149349 | USE OF COMPOUNDS WITH THROMBOPOIETIC ACTIVITY TO PROMOTE BONE GROWTH AND HEALING - TPO was used to promote the growth of bone in both rats and in mice. Gaps in both mouse and in rat bones were treated with a scaffold sized to fit the gap. Scaffolds that included TPO promoted better outcomes than scaffolds that included BMP-2 or scaffolds that did not include either TPO or BMP-2. These data indicate that compounds that exhibit thrombopoietic activity such a recombinant TPO can be used to promote bone growth and healing in mammals. | 06-13-2013 |
Melissa A. Martinetti, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20130273128 | Films and Compositions Comprising the Same - Described herein are water-stable films for use in aqueous compositions comprising one or more cellulosic polymers present in an amount from about 10 to about 50% of the film's dry weight, polyvinyl acetate present in an amount from about 8 to about 25% of the film's dry weight and metal particles, compositions for oral cavity comprising the films, and methods of making and using the same | 10-17-2013 |
20130280181 | Fluid Oral Care Compositions - Described herein are compositions comprising gums which are capable of suspending particles, and methods of making and using the same. | 10-24-2013 |
Melissa A. Mielcarek, Saginaw, MI US
Patent application number | Description | Published |
---|---|---|
20140094537 | AQUEOUS POUR POINT DEPRESSANT DISPERSION COMPOSITION - The present invention relates to an aqueous pour point depressant dispersion composition comprising a thermoplastic polymer, preferably ethylene vinyl acetate (EVA); a dispersing agent; water; optionally an aqueous freezing point depressant; and optionally a stabilizing agent wherein the volume average particle size of the dispersed thermoplastic polymer is equal to or less than 1 micrometers and a method to make and use said composition. | 04-03-2014 |
20150369822 | METHOD T0 MAKE AN AQUEOUS POUR POINT DEPRESSANT DISPERSION COMPOSITION - The present invention relates to an aqueous pour point depressant dispersion composition comprising a thermoplastic polymer, preferably ethylene vinyl acetate (EVA); a dispersing agent; water; optionally an aqueous freezing point depressant; and optionally a stabilizing agent wherein the volumn average particle size of the dispersed thermoplastic polymer is equal to or less than 1 micrometers and a method to make and use said composition. | 12-24-2015 |
Melissa A. Mushrush, Midland, MI US
Patent application number | Description | Published |
---|---|---|
20100139374 | METHODS FOR RHEOLOGICAL TESTING OF MULTIPLE SAMPLES AND SYSTEMS THEREFOR - The viscosity or relative viscosity of samples can be measured in parallel by dispensing or aspirating the samples at a set condition and then measuring a property of the sample such as mass dispensed or aspirated. | 06-10-2010 |
20140283907 | METHOD OF MANUFACTURE OF CHALCOGENIDE-BASED PHOTOVOLTAIC CELLS - The invention is a method of forming a cadmium sulfide based buffer on a copper chalcogenide based absorber in making a photovoltaic cell. The buffer is sputtered in two steps the first being at low rates or relatively high pressures and the second at high rates or relatively low pressures. The resulting cell has good efficiency and according to one embodiment is characterized by a narrow interface between the absorber and buffer layers. The buffer is further characterized according to a second embodiment by a relatively high oxygen content. | 09-25-2014 |
Melissa A. Ottens-Rendon, Waukesha, WI US
Patent application number | Description | Published |
---|---|---|
20100039068 | ELECTRICAL COMPONENT, SUCH AS A RADIO, MP3 PLAYER, AUDIO COMPONENT, BATTERY CHARGER, RADIO/CHARGER, MP3 PLAYER/RADIO, MP3 PLAYER/CHARGER OR MP3 PLAYER/RADIO/CHARGER, HAVING A SELECTIVELY CONNECTABLE BATTERY CHARGER - An electrical component, such as, for example, a radio, MP3 player, audio component, battery charger, radio/charger, MP3 player/radio, MP3 player/charger, or MP3 player/radio/charger. The electrical component includes a housing and an electrical circuit supported by the housing. In some aspects, the electrical component is an audio component and the electrical circuit is an audio circuit. In other aspects, the electrical component is a battery charger and the electrical circuit is a charging circuit. In further aspects, the electrical component is an MP3 player and the electrical circuit is a MP3 circuit. In yet further aspects, the electrical component is an combination of any or all of a radio, battery charger, and MP3 player and the electrical component can include any combination or all of the audio, radio, and MP3 circuits. A battery may be connectable to the housing and electrically connectable the electrical circuit. | 02-18-2010 |
20110068742 | AUDIO DEVICE THAT INTERFACES WITH A BATTERY CHARGER - Audio devices powered by rechargeable batteries or an external power source including a separate audio device housing and battery charger housing that are engageable with each other. The audio device housing and battery charger housing can share an external power source. Furthermore, when separated, the audio device housing and battery charger housing are usable alone to produce sound and to charge a battery, respectively. In some instances, a battery placed in a first position is charged and, when placed in a second position, provides power to the audio circuit. | 03-24-2011 |
20110227524 | Audio device with power tool battery and external battery charger - An electrical component, such as, for example, a radio, MP3 player, audio component, battery charger, radio/charger, MP3 player/radio, MP3 player/charger, or MP3 player/radio/charger. The electrical component includes a housing and an electrical circuit supported by the housing. In some aspects, the electrical component is an audio component and the electrical circuit is an audio circuit. In other aspects, the electrical component is a battery charger and the electrical circuit is a charging circuit. In further aspects, the electrical component is an MP3 player and the electrical circuit is a MP3 circuit. In yet further aspects, the electrical component is an combination of any or all of a radio, battery charger, and MP3 player and the electrical component can include any combination or all of the audio, radio, and MP3 circuits. A battery may be connectable to the housing and electrically connectable the electrical circuit. | 09-22-2011 |
Melissa A. Smith, Hampshire GB
Patent application number | Description | Published |
---|---|---|
20090203004 | NON-THIOPURINE METHYLTRANSFERASE RELATED EFFECTS IN 6-MERCAPTOPURINE THERAPY - The present invention provides methods for predicting tolerance associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. In particular, the present invention provides methods for predicting a patient's risk of an adverse drug reaction (or tolerance) to a 6-mercaptopurine drug by genotyping a patient at a polymorphic site in at least one gene selected from the group consisting of a xanthine dehydrogenase (XDH) gene, molybdenum cofactor sulfurase (MOCOS) gene, and aldehyde oxidase (AOX) gene. The present invention further provides methods for optimizing therapeutic efficacy in a patient receiving a 6-mercaptopurine drug by determining whether the patient should be given an alternative drug based on the presence or absence of a polymorphism in at least one of the XDH, MOCOS, and AOX genes. | 08-13-2009 |
20110287430 | NON-THIOPURINE METHYLTRANSFERASE RELATED EFFECTS IN 6-MERCAPTOPURINE THERAPY - The present invention provides methods for predicting tolerance associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. In particular, the present invention provides methods for predicting a patient's risk of an adverse drug reaction (or tolerance) to a 6-mercaptopurine drug by genotyping a patient at a polymorphic site in at least one gene selected from the group consisting of a xanthine dehydrogenase (XDH) gene, molybdenum cofactor sulfurase (MOCOS) gene, and aldehyde oxidase (AOX) gene. The present invention further provides methods for optimizing therapeutic efficacy in a patient receiving a 6-mercaptopurine drug by determining whether the patient should be given an alternative drug based on the presence or absence of a polymorphism in at least one of the XDH, MOCOS, and AOX genes. | 11-24-2011 |
20130022971 | NON-THIOPURINE METHYLTRANSFERASE RELATED EFFECTS IN 6-MERCAPTOPURINE THERAPY - The present invention provides methods for predicting tolerance associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. In particular, the present invention provides methods for predicting a patient's risk of an adverse drug reaction (or tolerance) to a 6-mercaptopurine drug by genotyping a patient at a polymorphic site in at least one gene selected from the group consisting of a xanthine dehydrogenase (XDH) gene, molybdenum cofactor sulfurase (MOCOS) gene, and aldehyde oxidase (AOX) gene. The present invention further provides methods for optimizing therapeutic efficacy in a patient receiving a 6-mercaptopurine drug by determining whether the patient should be given an alternative drug based on the presence or absence of a polymorphism in at least one of the XDH, MOCOS, and AOX genes. | 01-24-2013 |
Melissa A. Smith, Wappingers Falls, NY US
Patent application number | Description | Published |
---|---|---|
20160141237 | THREE DIMENSIONAL ORGANIC OR GLASS INTERPOSER - A three-dimensional organic structure or glass interposer structure and methods of manufacture are disclosed. The method includes forming lined metal vias in a substrate. The method further includes removing the substrate, leaving the lined metal vias. The method further includes forming a new substrate about the lined metal vias. The method also includes connecting the lined metal vias to wiring layers using back end of the line processes. | 05-19-2016 |
Melissa A. Tiongco, Glendale, CA US
Melissa A. Vanblaricom, Hudson, WI US
Patent application number | Description | Published |
---|---|---|
20100068249 | ABUSE-RESISTANT TRANSDERMAL DOSAGE FORM - The present invention comprises a transdermal dosage form comprising an active agent component having a skin contacting surface, an adverse agent component, and a barrier. The dosage form comprises at least one channel passing between proximal and distal surfaces of the active agent component. The barrier is interposed between the active agent component and the adverse agent component. In one aspect, the barrier is permeable to selected solvents and impermeable to diffusion of active and adverse agents in the absence of said solvent. In another aspect, the barrier is discontinuous, impermeable to diffusion of active and adverse agents, and the dosage form comprises at least one channel passing between the skin-contacting surface and the adverse agent component. | 03-18-2010 |